Exercise and muscle dysfunction in COPD: Implications for pulmonary rehabilitation

Clinical Science

Volumn 117, Issue 8, 2009, Pages 281-291

  Man, William D C ^a   Kemp, Paul ^a   Moxham, John ^b   Polkey, Michael I ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Exercise; Muscle dysfunction; Obstructive pulmonary disease; Pulmonary rehabilitation; Quadriceps; Skeletal muscle

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYLCYSTEINE; ANABOLIC AGENT; ANTIOXIDANT; BRONCHODILATING AGENT; CARBOCISTEINE; CORTICOSTEROID; CYCLOSPORIN; HELIOX; LIGASE INHIBITOR; NANDROLONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PLACEBO; PROTEIN SYNTHESIS INHIBITOR; RECOMBINANT GROWTH HORMONE; TESTOSTERONE; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ASSISTED VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG MECHANISM; EXERCISE; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MOLECULAR MECHANICS; MORTALITY; MOTOR PERFORMANCE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; SKELETAL MUSCLE; UNSPECIFIED SIDE EFFECT;

COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; EXERCISE THERAPY; HUMANS; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY;

EID: 70349382690     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080660     Document Type: Review

References (121)

1. Man, W. D.-C., Kemp, P., Moxham, J. and Polkey, M. I. (2009) Skeletal muscle dysfunction in COPD: clinical and laboratory observations. Clin. Sci. 117, 251-264
2. Belman, M. J. and Kendregan, B. A. (1981) Exercise training fails to increase skeletal muscle enzymes in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 123, 256-261
3. Lacasse, Y., Brosseau, L., Milne, S., Martin, S., Wong, E., Guyatt, G. H. and Goldstein, R. S. (2002) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., CD003793, doi: 10.1002/14651858.CD003793.pub2.
4. Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., Carone, M., Celli, B., Engelen, M., Fahy, B. et al. (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 173, 1390-1413
5. Troosters, T., Casaburi, R., Gosselink, R. and Decramer, M. (2005) Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 172, 19-38
6. Whittom, F., Jobin, J., Simard, P. M., Leblanc, P., Simard, C., Bernard, S., Belleau, R. and Maltais, F. (1998) Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med. Sci. Sports Exercise 30, 1467-1474
7. Griffiths, T. L., Burr, M. L., Campbell, I. A., Lewis-Jenkins, V., Mullins, J., Shiels, K., Turner-Lawlor, P. J., Payne, N., Newcombe, R. G., Ionescu, A. A. et al. (2000) Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355, 362-368
8. Troosters, T., Gosselink, R. and Decramer, M. (2000) Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am. J. Med. 109, 207-212
9. Pulmonary Rehabilitation Survey (2003) British Thoracic Society, British Lung Foundation, London
10. Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P. and Anto, J. M. (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61, 772-778
11. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A. and Nathan, D. M. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403
12. Spruit, M. A., Gosselin, R., Troosters, T., De Paepe, K. and Decramer, M. (2002) Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur. Respir. J. 19, 1072-1078
13. Pette, D. and Staron, R. S. (2001) Transitions of muscle fiber phenotypic profiles. Histochem. Cell Biol. 115, 359-372
14. Thomas, D. R. (2007) Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin. Nutr. 26, 389-399
15. Glass, D. J. (2005) Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37, 1974-1984
16. Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., Wu, H., Zhu, W., Bassel-Duby, R. and Williams, R. S. (1998) A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12, 2499-2509
17. Naya, F. J., Mercer, B., Shelton, J., Richardson, J. A., Williams, R. S. and Olson, E. N. (2000) Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J. Biol. Chem. 275, 4545-4548
18. Schaeffer, P. J., Wende, A. R., Magee, C. J., Neilson, J. R., Leone, T. C., Chen, F. and Kelly, D. P. (2004) Calcineurin and calcium/ calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle. J. Biol. Chem. 279, 39593-39603
19. Terada, S., Nakagawa, H., Nakamura, Y. and Muraoka, I. (2003) Calcineurin is not involved in some mitochondrial enzyme adaptations to endurance exercise training in rat skeletal muscle. Eur. J. Appl. Physiol. 90, 210-217
20. Garcia-Roves, P. M., Huss, J. and Holloszy, J. O. (2006) Role of calcineurin in exercise-induced mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 290, E1172-E1179
21. Ryder, J. W., Bassel-Duby, R., Olson, E. N. and Zierath, J. R. (2003) Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J. Biol. Chem. 278, 44298-44304
22. Garcia-Roves, P. M., Jones, T. E., Otani, K., Han, D. H. and Holloszy, J. O. (2005) Calcineurin does not mediate exercise-induced increase in muscle GLUT4. Diabetes 54, 624-628
23. Wu, H., Kanatous, S. B., Thurmond, F. A., Gallardo, T., Isotani, E., Bassel-Duby, R. and Williams, R. S. (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296, 349-352
24. 2+/ calmodulin-dependent protein kinase IV-deficient mice. Am. J. Physiol. Cell Physiol. 287, C1311-C1319
25. 2+. Am. J. Physiol. Endocrinol. Metab. 282, E1008-E1013
26. Lin, J., Wu,H., Tarr, P. T., Zhang, C. Y.,Wu, Z., Boss,O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N. et al. (2002) Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418, 797-801
27. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C. and Spiegelman, B. M. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124
28. Vega, R. B., Huss, J. M. and Kelly, D. P. (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20, 1868-1876
29. Baar, K., Wende, A. R., Jones, T. E., Marison, M., Nolte, L. A., Chen, M., Kelly, D. P. and Holloszy, J. O. (2002) Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 16, 1879-1886
30. Calvo, J. A., Daniels, T. G., Wang, X., Paul, A., Lin, J., Spiegelman, B. M., Stevenson, S. C. and Rangwala, S. M. (2008) Muscle-specific expression of PPAR? coactivator-1α improves exercise performance and increases peak oxygen uptake. J. Appl. Physiol. 104, 1304-1312
31. Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., Lebrasseur, N. K., Yan, Z. and Spiegelman, B. M. (2007) Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem. 282, 30014-30021
32. Russell, A. P., Feilchenfeldt, J., Schreiber, S., Praz, M., Crettenand, A., Gobelet, C., Meier, C. A., Bell, D. R., Kralli, A., Giacobino, J. P. and Deriaz, O. (2003) Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 52, 2874-2881
33. Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R. and Schols, A. M. (2007) Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur. Respir. J. 30, 245-252
34. Suwa, M., Nakano, H. and Kumagai, S. (2003) Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. 95, 960-968
35. Winder,W.W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M. and Holloszy, J. O. (2000) Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88, 2219-2226
36. Rockl, K. S., Hirshman, M. F., Brandauer, J., Fujii, N., Witters, L. A. and Goodyear, L. J. (2007) Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56, 2062-2069
37. Lee,W. J., Kim, M., Park, H. S.,Kim,H. S., Jeon, M. J., Oh, K. S., Koh, E.H., Won, J.C., Kim, M. S., Oh, G. T. et al. (2006) AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1. Biochem. Biophys. Res. Commun. 340, 291-295
38. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H. et al. (2008) AMPK and PPARδ agonists are exercise mimetics. Cell 134, 405-415
39. Jager, S., Handschin, C., St-Pierre, J. and Spiegelman, B. M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 104, 12017-12022
40. Kimball, S. R. (2006) Interaction between the AMP-activated protein kinase and mTOR signaling pathways. Med. Sci. Sports Exercise 38, 1958-1964
41. Krawiec, B. J.,Nystrom, G. J., Frost, R. A., Jefferson, L. S. and Lang, C. H. (2007) AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells. Am. J. Physiol. Endocrinol. Metab. 292, E1555-E1567
42. Ries, A. L., Kaplan, R. M., Limberg, T. M. and Prewitt, L. M. (1995) Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann. Intern. Med. 122, 823-832
43. Bernard, S.,Whittom, F., Leblanc, P., Jobin, J., Belleau, R., Berube, C., Carrier, G. and Maltais, F. (1999) Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159, 896-901
44. O'Donnell, D. E., McGuire, M., Samis, L. and Webb, K. A. (1998) General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am. J. Respir. Crit. Care Med. 157, 1489-1497
45. Ortega, F., Toral, J., Cejudo, P., Villagomez, R., Sanchez, H., Castillo, J. and Montemayor, T. (2002) Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 166, 669-674
46. Mador, M. J., Kufel, T. J., Pineda, L. A., Steinwald, A., Aggarwal, A., Upadhyay, A. M. and Khan, M. A. (2001) Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. Am. J. Respir. Crit. Care Med. 163, 930-935
47. Casaburi, R., Bhasin, S., Cosentino, L., Porszasz, J., Somfay, A., Lewis, M. I., Fournier, M. and Storer, T.W. (2004) Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170, 870-878
48. Creutzberg, E. C., Wouters, E. F., Mostert, R., Pluymers, R. J. and Schols, A. M. (2003) A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 124, 1733-1742
49. Maltais, F., LeBlanc, P., Simard, C., Jobin, J., Berube, C., Bruneau, J., Carrier, L. and Belleau, R. (1996) Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154, 442-447
50. Casaburi, R., Patessio, A., Ioli, F., Zanaboni, S., Donner, C. F. and Wasserman, K. (1991) Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am. Rev. Respir. Dis. 143, 9-18
51. Sala, E., Roca, J., Marrades, R. M., Alonso, J., Gonzalez De Suso, J. M., Moreno, A., Barbera, J. A., Nadal, J., de Jover, L., Rodriguez-Roisin, R. and Wagner, P. D. (1999) Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159, 1726-1734
52. Couillard, A. and Prefaut, C. (2005) From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur. Respir. J. 26, 703-719
53. Wagner, P. D. (2006) Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy? Respirology 11, 681-686
54. 2 with small muscle mass exercise. Am. J. Respir. Crit. Care Med. 169, 89-96
55. Guell, R., Casan, P., Belda, J., Sangenis, M., Morante, F., Guyatt, G. H. and Sanchis, J. (2000) Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 117, 976-983
56. Sewell, L., Singh, S. J., Williams, J. E., Collier, R. and Morgan, M. D. (2006) How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax 61, 767-771
57. Pitta, F., Troosters, T., Probst, V. S., Langer, D., Decramer, M. and Gosselink, R. (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134, 273-280
58. Belman, M. J., Botnick, W. C. and Shin, J. W. (1996) Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153, 967-975
59. O'Donnell, D. E., Lam, M. and Webb, K. A. (1998) Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158, 1557-1565
60. Man, W. D., Mustfa, N., Nikoletou, D., Fleming, T. A., Wood, C. N., Kaul, S., Hart, N., Rafferty, G. F., Polkey, M. I. and Moxham, J. (2003) The effect of salmeterol on dynamic hyperinflation and exercise induced dyspnea in poorly reversible COPD. Am. J. Respir. Crit. Care Med. 167, A313
61. O'Donnell, D. E., Revill, S. M. and Webb, K. A. (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 770-777
62. Casaburi, R., Kukafka, D., Cooper, C. B., Witek, Jr, T. J. and Kesten, S. (2005) Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127, 809-817
63. Saey, D., Debigare, R., LeBlanc, P., Mador, M. J., Cote, C. H., Jobin, J. and Maltais, F. (2003) Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 168, 425-430
64. Somfay, A., Porszasz, J., Lee, S. M. and Casaburi, R. (2001) Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur. Respir. J. 18, 77-84
65. O'Donnell, D. E., D'Arsigny, C. and Webb, K. A. (2001) Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 892-898
66. O'Donnell, D. E., Bain, D. J. and Webb, K. A. (1997) Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am. J. Respir. Crit. Care Med. 155, 530-535
67. Stein, D. A., Bradley, B. L. and Miller, W. C. (1982) Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 81, 6-10
68. 2 uptake during exercise in COPD. Med. Sci. Sports Exercise 33, 916-922
69. Garrod, R., Paul, E. A. and Wedzicha, J. A. (2000) Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 55, 539-543
70. Wadell, K., Henriksson-Larsen, K. and Lundgren, R. (2001) Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia. J. Rehabil. Med. 33, 200-205
71. Palange, P., Valli, G., Onorati, P., Antonucci, R., Paoletti, P., Rosato, A., Manfredi, F. and Serra, P. (2004) Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J. Appl. Physiol. 97, 1637-1642
72. Laude, E. A., Duffy, N. C., Baveystock, C., Dougill, B., Campbell, M. J., Lawson, R., Jones, P. W. and Calverley, P. M. (2006) The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am. J. Respir. Crit. Care Med. 173, 865-870
73. Johnson, J. E., Gavin, D. J. and Adams-Dramiga, S. (2002) Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD. Chest 122, 464-472
74. Lightowler, J. V., Wedzicha, J. A., Elliott, M. W. and Ram, F. S. (2003) Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Br. Med. J. 326, 185
75. Appendini, L., Patessio, A., Zanaboni, S., Carone, M., Gukov, B., Donner, C. F. and Rossi, A. (1994) Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 149, 1069-1076
76. Keilty, S. E., Ponte, J., Fleming, T. A. and Moxham, J. (1994) Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax 49, 990-994
77. Maltais, F., Reissmann, H. and Gottfried, S. B. (1995) Pressure support reduces inspiratory effort and dyspnea during exercise in chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 151, 1027-1033
78. Hawkins, P., Johnson, L. C., Nikoletou, D., Hamnegard, C. H., Sherwood, R., Polkey, M. I. and Moxham, J. (2002) Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax 57, 853-859
79. Costes, F., Agresti, A., Court-Fortune, I., Roche, F., Vergnon, J. M. and Barthelemy, J. C. (2003) Noninvasive ventilation during exercise training improves exercise tolerance in patients with chronic obstructive pulmonary disease. J. Cardiopulm. Rehabil. 23, 307-313
80. Bianchi, L., Foglio, K., Porta, R., Baiardi, R., Vitacca, M. and Ambrosino, N. (2002) Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients. Respir. Med. 96, 359-367
81. Revill, S. M., Singh, S. J. and Morgan, M. D. (2000) Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir. Med. 94, 778-783
82. Man, W. D., Polkey, M. I., Donaldson, N., Gray, B. J. and Moxham, J. (2004) Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. Br. Med. J. 329, 1209
83. Behnke, M., Taube, C., Kirsten, D., Lehnigk, B., Jorres, R. A. and Magnussen, H. (2000) Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir. Med. 94, 1184-1191
84. Garrod, R., Mikelsons, C., Paul, E. A. and Wedzicha, J. A. (2000) Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162, 1335-1341
85. Byrd, R. B. and Hyatt, R. E. (1968) Maximal respiratory pressures in chronic obstructive lung disease. Am. Rev. Respir. Dis. 98, 848-856
86. Man, W. D., Soliman, M. G., Nikoletou, D., Harris, M. L., Rafferty, G. F., Mustfa, N., Polkey, M. I. and Moxham, J. (2003) Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 58, 665-669
87. Similowski, T., Yan, S., Gauthier, A. P., Macklem, P. T. and Bellemare, F. (1991) Contractile properties of the human diaphragm during chronic hyperinflation. N. Engl. J. Med. 325, 917-923
88. Levine, S., Kaiser, L., Leferovich, J. and Tikunov, B. (1997) Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N. Engl. J. Med. 337, 1799-1806
89. Polkey, M. I., Kyroussis, D., Keilty, S. E., Hamnegard, C. H., Mills, G. H., Green, M. and Moxham, J. (1995) Exhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPD. Am. J. Respir. Crit. Care Med. 152, 959-964
90. Ramirez-Sarmiento, A., Orozco-Levi, M., Guell, R., Barreiro, E., Hernandez, N., Mota, S., Sangenis, M., Broquetas, J. M., Casan, P. and Gea, J. (2002) Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am. J. Respir. Crit. Care Med. 166, 1491-1497
91. Lotters, F., van Tol, B., Kwakkel, G. and Gosselink, R. (2002) Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur. Respir. J. 20, 570-576
92. Orozco-Levi, M., Lloreta, J., Minguella, J., Serrano, S., Broquetas, J. M. and Gea, J. (2001) Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1734-1739
93. Neder, J. A., Sword, D., Ward, S. A., Mackay, E., Cochrane, L. M. and Clark, C. J. (2002) Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 57, 333-337
94. Bourjeily-Habr, G., Rochester, C. L., Palermo, F., Snyder, P. and Mohsenin, V. (2002) Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 57, 1045-1049
95. Zanotti, E., Felicetti, G., Maini, M. and Fracchia, C. (2003) Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 124, 292-296
96. Schols, A. M., Soeters, P. B., Dingemans, A. M., Mostert, R., Frantzen, P. J. and Wouters, E. F. (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am. Rev. Respir. Dis. 147, 1151-1156
97. Vestbo, J., Prescott, E., Almdal, T., Dahl, M., Nordestgaard, B. G., Andersen, T., Sorensen, T. I. and Lange, P. (2006) Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am. J. Respir. Crit. Care Med. 173, 79-83
98. Steiner, M. C., Barton, R. L., Singh, S. J. and Morgan, M. D. (2003) Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 58, 745-751
99. Whittaker, J. S., Ryan, C. F., Buckley, P. A. and Road, J. D. (1990) The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am. Rev. Respir. Dis. 142, 283-288
100. Ferreira, I. M., Brooks, D., Lacasse, Y. and Goldstein, R. S. (2000) Nutritional supplementation in stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., CD000998, doi:10.1002/ 14651858.CD000998.pub2
101. Creutzberg, E. C., Wouters, E. F., Mostert, R., Weling-Scheepers, C. A. and Schols, A. M. (2003) Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 19, 120-127
102. Yeh, S. S., DeGuzman, B. and Kramer, T. (2002) Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest 122, 421-428
103. Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J. and Wouters, E. F. (1995) Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am. J. Respir. Crit. Care Med. 152, 1268-1274
104. Ferreira, I. M., Verreschi, I. T., Nery, L. E., Goldstein, R. S., Zamel, N., Brooks, D. and Jardim, J. R. (1998) The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 114, 19-28
105. Laghi, F., Antonescu-Turcu, A., Collins, E., Segal, J., Tobin, D. E., Jubran, A. and Tobin, M. J. (2005) Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. Am. J. Respir. Crit. Care Med. 171, 728-733
106. Van Vliet, M., Spruit, M. A., Verleden, G., Kasran, A., Van Herck, E., Pitta, F., Bouillon, R. and Decramer, M. (2005) Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 172, 1105-1111
107. Lewis, M. I., Fournier, M., Storer, T.W., Bhasin, S., Porszasz, J., Ren, S. G., Da, X. and Casaburi, R. (2007) Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J. Appl. Physiol. 103, 1299-1310
108. Burdet, L., de Muralt, B., Schutz, Y., Pichard, C. and Fitting, J.W. (1997) Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med. 156, 1800-1806
109. Adams, G. R. and McCue, S. A. (1998) Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J. Appl. Physiol. 84, 1716-1722
110. Boonen, S., Rosen, C., Bouillon, R., Sommer, A., McKay, M., Rosen, D., Adams, S., Broos, P., Lenaerts, J., Raus, J. et al. (2002) Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J. Clin. Endocrinol. Metab. 87, 1593-1599
111. Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P. et al. (2007) The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175, 926-934
112. Zheng, J. P., Kang, J., Huang, S. G., Chen, P., Yao, W. Z., Yang, L., Bai, C. X., Wang, C. Z., Wang, C., Chen, B. Y. et al. (2008) Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 371, 2013-2018
113. Kanter, M. M., Nolte, L. A. and Holloszy, J. O. (1993) Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J. Appl. Physiol. 74, 965-969
114. Koechlin, C., Couillard, A., Simar, D., Cristol, J. P., Bellet, H., Hayot, M. and Prefaut, C. (2004) Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 169, 1022-1027
115. Hansen, M. J., Gualano, R. C., Bozinovski, S., Vlahos, R. and Anderson, G. P. (2006) Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease). Pharmacol. Ther. 109, 162-172
116. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K. et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708
117. Doucet, M., Russell, A. P., Leger, B., Debigare, R., Joanisse, D. R., Caron, M. A., LeBlanc, P. and Maltais, F. (2007) Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 176, 261-269
118. Bogdanovich, S., Krag, T. O., Barton, E. R., Morris, L. D., Whittemore, L. A., Ahima, R. S. and Khurana, T. S. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421
119. Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., Flanigan, K. M., Pestronk, A., Tawil, R., Wolfe, G. I. et al. (2008) A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 63, 561-571
120. Handschin, C. and Spiegelman, B. M. (2008) The role of exercise and PGC1α in inflammation and chronic disease. Nature 454, 463-469
121. Arany, Z., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D. and Spiegelman, B. M. (2008) Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1α and oxidative phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 4721-4726